Peri-transplant RBC Transfusion is Associated with Increased Risk of GvHD after Allogeneic Stem Cell Transplantation

More than 90% of allogeneic hematopoietic stem cell transplant (allo-HSCT) patients receive red blood cell (RBC) or platelet transfusions in the peritransplant period. We tested the hypothesis that transfusions are associated with development of severe acute graft-versus-host disease (grade III/IV a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Hosoba, Sakura, Waller, Edmund K., Shenvi, Neeta, Graiser, Michael, Easley, Kirk A., Al-Kadhimi, Zaid, Andoh, Akira, Antun, Ana G., Barclay, Sheliagh, Josephson, Cassandra D., Koff, Jean L., Khoury, H. Jean, Langston, Amelia A., Zimring, James C., Roback, John D., Giver, Cynthia R.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5953791/
https://ncbi.nlm.nih.gov/pubmed/29307717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.01.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars